Three months ended 31 Mar

Key Consolidated Statement of
Comprehensive Income Items
2021
US$ mn
(unaudited)
2020
US$ mn
(unaudited)
     
Revenue 1,132 1,007
Gross Profit 317 337
Share of Profit of a 35%-owned Associate - CTI 44 -
Profit Attributable to Shareholders 137 133
Profit Attributable to Shareholders before Biological Assets Fair Value Changes 161 158
     
     
     
  As at 31 Mar
2021
As at 31 Dec
2020
Key Consolidated Statement of
Financial Position Items
(unaudited)
US$ mn
(audited)
US$ mn
     
Property, Plant & Equipment 1,603 1,589
Investment in Associates 2,367 2,331
Total Assets 6,733 6,597
Bank Borrowings & Corporate Bond 1,035 1,136
Issued Capital 253 253
Shareholders' Equity 3,669 3,548
Total Equity 4,211 4,033